In the ICONIC-LEAD study, once-daily icotrokinra showed significant skin clearance versus placebo in adults and adolescents with moderate to severe plaque psoriasis. At week 16, nearly two-thirds of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback